Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C Virus Infection

Explore clinical trials studying Hepatitis C Virus Infection. Study availability and eligibility vary by location and protocol.

79 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C Virus Infection trial results

Completed

Evaluation Study of HCV RDTs in Fresh Samples

NCT04139941

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Sihanouk Hospital Centre of Hope Phnom Penh, Cambodia
  • National Center for Disease Control & Public Health/Lugar Center Tbilisi, Georgia
View Trial Details
Completed

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection

NCT02378935

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • Huntington Memorial Hospital Liver Center Pasadena, California, United States
  • Medical Associates Research Group, Inc. San Diego, California, United States
View all 34 locations
View Trial Details
Completed

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection

NCT02378961

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • Huntington Memorial Hospital Liver Center Pasadena, California, United States
  • Medical Associates Research Group, Inc. San Diego, California, United States
View all 34 locations
View Trial Details
Completed

Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease

NCT03036839

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • James J. Peters VA Hospital The Bronx, New York, United States
  • The Liver Institute at Methodist Dallas Medical Center Dallas, Texas, United States
View all 21 locations
View Trial Details
Completed

Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis

NCT02994056

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Tampa General Medical Group Tampa, Florida, United States
  • Northwestern Memorial Hospital; Clinical Research Unit Chicago, Illinois, United States
  • Digestive Disease Associates, PA Catonsville, Maryland, United States
  • Southern Therapy and Advanced Research LLC Jackson, Mississippi, United States
View Trial Details

Related conditions